The Korean Journal of Food And Nutrition (한국식품영양학회지)

The Korean Society of Food and Nutrition (한국식품영양학회)
권호 표지
DOI QR코드

DOI QR Code

[Lactic Acid Bacteria] Probiotic Lactic Acid Bacteria

[유산균] 프로바이오틱 유산균

  • Ann, Yong-Geun (Dept. of Food and Nutrition, Chungcheong University)
  • 안용근 (충청대학 식품영양학부)
  • Received : 2011.12.09
  • Accepted : 2011.12.15
  • Published : 2011.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

It is said that the reason Bulgarians enjoy longevity is that they have a lot of yogurt, whose $Lactobacillus$ controls intestinal poison-producing germs. In young individuals, the number of bifidobacteria exceeds 10 billion per 1 g of intestinal content, but this number decreases for older or senile individuals, who have a larger number of harmful microorganisms such as $Clostridium$. In addition, it is well known that artificially increasing intestinal bifidobacteria can help control harmful microorganisms and thus facilitate a healthier and longer life. The microorganisms used for artificial spawn are referred to as probiotic microorganisms, and in general, lactic acid bacteria(LAB) are used. Unlike antibiotics, which kill harmful microorganisms, probiotic microorganisms coexist with and control them, while improving the health of the individual, that is, they can improve and invigorate host cells. Because probiotic microorganisms and its products based on LAB are known to help prevent and treat constipation, diarrhea, intestinal inflammation, and blood cholesterol and generally improve health through the purification of intestines, its market has been continuously expanding. Korea imports approximately 90% of spawn and uses them. It is likely that they are not appropriate for Korean's physical condition. Thus, considering this problem into account, Entecbio, a biotech firm in Korea, has produced various products by using its proprietary microorganisms. In this paper, the effects, characteristics, and kinds of products from based on proprietary microorganisms, with its prospect for market, etc., are generally examined.

불가리아 사람들이 장수하는 것은 요구르트를 많이 섭취하여 유산균이 장내의 독소 생성 세균을 억제하기 때문이라고 한다. 젊을 때는 사람의 장 내용물 1 g당 100억 마리 이상의 $Bifidobacterium$이 살지만 노쇠하거나 병들면서 줄어들고 $Clostridium$ 등의 유해균이 많아진다. 그래서 인공적으로 장내의 비피도박테리움을 증가시키면 유해세균이 억제되어 건강하고 장수한다고 한다. 이를 위하여 섭취하는 미생물을 probiotic 미생물이라고 하며, 주로 유산균이 사용된다. 프로바이오틱 미생물은 항생제와 같이 유해균을 죽이는 것이 아니라 유해균과 공생하면서 유해균을 억제하여 건강을 증진, 즉 숙주(사람)를 증생(增生)시킨다. 그래서 유산균을 주체로 하는 프로바이오틱 미생물과 그 제품은 변비, 설사, 장염, 혈중 콜레스테롤, 암 등을 예방 내지 치료하고 정장(淨腸) 작용으로 건강을 향상시킨다고 하여 시장이 계속 확대되고 있다. 그러나 국내 프로바이오틱스 제품은 종균을 대부분(90%) 수입하여 사용하므로 한국인의 체질에 적합하지 않을 가능성이 있다. 그래서 E사는 자체 개발한 미생물로 제품을 생산하고 있다. 본 논문에서는 유산균을 주체로 하는 프로바이오틱 미생물과 제품의 효과와 특성, 종류, 시장 등 전반적인 면을 살펴 보았다.

Keywords

References

  1. Agrebaek M, Gerdes LU, Richenlsen B. 1995. Hypocholesterolaemic effect of a new fermented milkproduct in healthy middleaged man. J Chin Natr 49:346-352
  2. Ahn YT, Kim BH, Kim HU. 2000. Effect of acidophilus milk on the reduction of serum cholesterol level of Korea adults. Korea J Animal Sci 42:223-234
  3. Allen SJ, Okoko B, Martinez EG, Gregorio GV, Dans LF. 2004. Probiotics for treating infectious diarrhea. Art No CD003048. Cochrane Database of Systematic Reviews
  4. Anand SKR, Srinivasan A, Rao LK. 1985. Antibacterial activity associated with Bifidobacterium bifidum. Cult Dairy Prod J 20, 21, 23
  5. Attaie R, Whalen PJ, Shahani KM, Amer MA. 1987. The effect of Lactobacillus acidophilus administration upon survival of Salmonella in randomly selected human carriers. Prog Food Nutr Sci 7:13-17
  6. Ayebo AD, Angele IA, Shahani KM. 1980. Effect of ingesting Lactobacillus acidophilus milk upon fecal flora and enzyme activity in human. Milchwissenscbaft 35:730-733
  7. Bellomo G, Mangiagle A, Nicastro L, Frigerio GA. 1980. A controlled double-blind study of SF68 strain as a new biological preparation for the treatment of diarrhea in pediatrics. Curr Ther Res 28:927-936
  8. Berg RD. 1996. The indigenous gastrointestinal microflora. Trends Microbio 4:430-435 https://doi.org/10.1016/0966-842X(96)10057-3
  9. Biller JA, Katz AJ, Flore AF, Buie TM, Gorbach SL. 1995. Treatment of recurrent Clostridium difficile GG. J Pediatr Gastroenterol Nutr 21:224-226 https://doi.org/10.1097/00005176-199508000-00016
  10. Bjorksten B, Naaber P, Sepp E, Mikelsaar M. 1999. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 29:342-346 https://doi.org/10.1046/j.1365-2222.1999.00560.x
  11. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. 2001. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 108:516-520 https://doi.org/10.1067/mai.2001.118130
  12. Bouvier M, Meance S, Bouley C, Berta JL, Grimaud JC. 2001. Effects of consumption of a milk fermented by the probiotic strain Bifidobacterium animalis DN-173010 on colonic transit times in healthy humans. Biosci Microflora 20:43-48 https://doi.org/10.12938/bifidus1996.20.43
  13. Burkhardt O, Kohnlein T, Pletz M, Welte T. 2005. Saccharomyces boulardil induced sepsis: Successful therapy with voriconazole. Scand J Infect Dis 37: 69-72 https://doi.org/10.1080/00365540510026454
  14. Donnet-Hughes A, Rochat F, Serrant P, Aechlimann JM, Schiffrin EJ. 1999. Modulation of nonspecific mechanisms of defense by lactic acid bacteria: Effective dose. J Dairy Sci 82:863- 869 https://doi.org/10.3168/jds.S0022-0302(99)75304-X
  15. Fernades CF, Shahani KM, Amer MA. 1987. Therapeutic role of dietary lactobacilli and lactobaciliic fermented dairy products. Microbial Reviewa 46:343-356
  16. Fernandes CF, Shahani KM. 1990. Anticarcinogenic and immunological properties of dietary lactobacilli. J Food Protec 53:704-710 https://doi.org/10.4315/0362-028X-53.8.704
  17. Fisher K, Johnson MC, Ray B. 1998. Lactose hydrolyzing enzymes in Lactobacillus acidophilus strains. Food Microbi 2:23-39
  18. Flohr C, Pascoe D, Williams HC. 2005. Atopic dermatitis and the 'hygiene hypothesis': Too clean to be true? Br J Dermatol 152:202-216 https://doi.org/10.1111/j.1365-2133.2004.06436.x
  19. Fujiwara S, Hashiba H, Hirota T, Forstner JF. 1997. Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Appl Environ Microbiol 63:506-512
  20. Fukui M, Fujino T, Tsutsui K, Maruyama T, Yoshimura H, Shinohara T, Nada O. 2001. The tumor-preventing dairy products. Microbial Reviewa 46:343-356
  21. Fukushima YY, Kawta H, Hara A, Mitsuoka T. 1998. Effect of a probiotic in healthy children. Int J Food Microbiol 42: 39-44 https://doi.org/10.1016/S0168-1605(98)00056-7
  22. Fuller R. 1989. Probiotics in man and animals. J Appl Bacteriol 66:365-378 https://doi.org/10.1111/j.1365-2672.1989.tb05105.x
  23. Gallager CR, Molleson AL, Caldwel JH. 1974. Lactose intolerance and fermented dairy products. J Am Dietetic Assoc 65:418- 419
  24. Gegnon M, Kheadr EE, Blay G, Fliss I. 2004. In vitro inhibition of Escherichia coli O157:H7 by bifidobacterial strains of human orgin. Int J Food Microbiol 92:69-78 https://doi.org/10.1016/j.ijfoodmicro.2003.07.010
  25. Gilliand SE, Nelson CR, Maxwell C. 1985. Assimilation of choleterol by Lactobacillus acidophilus. Appl Environ Microbiol 49:377-381
  26. Gilliand SE, Speak ML. 1977. Antagonistic action of Lactobacillus acidophilus toward intestinal and forborne pathogens in associative culture. J Food Prot 40:820-826 https://doi.org/10.4315/0362-028X-40.12.820
  27. Gilliland SE. 1990. Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol Rev 87:174-188
  28. Goldin B, Swenson L, Dwyer J, Sexton M, Gorbach SL. 1980. Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J Nat Cancer Inst 64:225- 260
  29. Goldin BR, Gorbach SL. 1984. The effect of milk and Lactobacillus feeding on human intestinal bacterial enzyme activity. Am J Clin Nutr 39:756-761 https://doi.org/10.1093/ajcn/39.5.756
  30. Gurr MI. 1987. Nutritional aspects of fermented milk products. Microbial Reviews 46:337-342
  31. He F, Ouwehand AC, lsolauri E, Hashimoto H, Benno Y, Salminen S. 2001. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 30:43-47 https://doi.org/10.1111/j.1574-695X.2001.tb01548.x
  32. Hepner G, Fried R, Jeor ST, Fusetti I, Morin R. 1979. Hypocholesterolemic effect of yogurt and milk. Am J Clin Nutr 32:19-24 https://doi.org/10.1093/ajcn/32.1.19
  33. Hitchins AD, Wells P, McDonough FE, Wong NP. 1985. Amelioration of the adverse effect of a gastrointestinal challenge with Salmonella enteritis on weaning rat by a yogurt ciet. Am J Clin Nutr 41:92-100 https://doi.org/10.1093/ajcn/41.1.92
  34. Homma, N. 1998. Bifidobacteria as a resistance factor in human beings. Bifidobact Microfl 7:35-43
  35. Hotta M, Sato Y, Iwata S, Yamashita N, Sunakawa K, Oikawa T, Tanaka R, Watanabe K, Takayama H, Yajima M, Sekiguchi S, Arai S, Sakurai T, Mutai M. 1987. Clinical effects of Bifidobacterium preparations on pediatric intractable diarrhea Keio J Med 36:298-314 https://doi.org/10.2302/kjm.36.298
  36. Jaspers DA, Massey LK, Luedecke LO. 1984. Effect of consuming yoghurts prepared with three culture strains on human serum lipoproteins. J Food Sci 49:1178-1181 https://doi.org/10.1111/j.1365-2621.1984.tb10422.x
  37. Jin SK, Kim IS, Song YM, Hah KH. 2003. Effects of dietary oils and tocopherol on fatty acid, amino acid, TBARS, VBN and sensory characteristics of pork meat. J Anim Sci Technol 45:397-308 https://doi.org/10.5187/JAST.2003.45.3.397
  38. Jo SJ, Hong CO, Yang SU, Choi KK, Kim HK, Yang H, Lee KW. 2011. Changes in contents of γ-aminobutyric acid (GABA) and isoflavones in traditional Korean Doenjang by ripening periods. J Korean Soc Food Nutr 40:557-564 https://doi.org/10.3746/jkfn.2011.40.4.557
  39. Kabir AMA, Aiba, Y, Takagi A, Kamiga S, Miwi T, Koga Y. 1997. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 41:49-55 https://doi.org/10.1136/gut.41.1.49
  40. Kalliomki M, Kirjavainen P, Eorola E, Kero P, Salminen S, lsolauri E. 2001. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 107:129-134 https://doi.org/10.1067/mai.2001.111237
  41. Kennedy MJ, Roger AL, Yancey RJ. 1988. An anaerobic continuous flow culture model of interactions between intestinal microflora and Candida albacans. Mycopathologia 103:125-134 https://doi.org/10.1007/BF00436810
  42. Kim CH, Park JS, Sohn HS, Chung CW. 2002. Determination of isoflavone, dietary fiber, soyoligosaccharides and lecithins from commercial soy products based on the one serving size. Korean J Food Sic Tec 34:96-102
  43. Kim H, Lee SY. Ji GE. 2005. Timing of Bifidobacterium administration influences the development of allergy to ovalbumin in mice. Biotechnol Lett 27:1361-1367 https://doi.org/10.1007/s10529-005-3682-9
  44. Kim HK. 2002. Probiotic characterization of lactic acid bacteria used for fermented milk. Mster thesis, Chungnam University
  45. Kim HS, Gilliland SE. 1983. Lactobacillus acidophilus as a dietary adjunct for milk to aid lactose digestion in humans. J Dairy Sci 66:956-966
  46. Kim JY, Choi YO, Ji GE. 2008. Effect of oral probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model. J Microbiol Biotechnol 18:1393-1400
  47. Kim JY, Kwon JH, Ahn SH, Lee SI, Han YS, Choi YO, Lee SY, Ahn KM, Ji GE. 2010. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a doubleblind, randomized, placebo-controlled trial. Pediatr Allergy Immunol 21:386-393 https://doi.org/10.1111/j.1399-3038.2009.00958.x
  48. Kiyosawa H, Sugawara C, Sugawara N, Miyake H. 1984. Effect of skim milk and yogurt on serum lipids and development of sudanophilic leisions in cholestrol-fed rabits. Am J Clin Nuty 40:479-484 https://doi.org/10.1093/ajcn/40.3.479
  49. Klaenhammer TR. 1993. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev 12:338-356
  50. Kohwi Y, Hashimoto Y, Tamura Z. 1982. Anti-tumor and immunological adjunct effect of Bifidobacterium infantis in mice. Bifidobac Microfl 1:61-66 https://doi.org/10.12938/bifidus1982.1.1_61
  51. Kullen MJ, Amann MM, O'Shaughnessy MJ, O'Sullivan DJ, Busta FF, Brady LJ. 1997. Differentiation of ingested and endogenous bifidobacteria by DNA fingerprinting demonstrates the survival of an unmodified strain in the gastrointestinal tract of humans. J Nutr 127:89-94 https://doi.org/10.1093/jn/127.1.89
  52. Lidbeak A, Geltner AU. 1991. Impact of Lactobacillus acidophilus supplement on the fecal microflora and soluble fecal bile acid in colon cancer patients. Microb Eco Hltb Dis 4:81-88 https://doi.org/10.3109/08910609109140267
  53. Lievin V, Peiffer I, Hudault S, Rochat F, Brassart D, Neeser JR, Servin AL. 2000. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut 47:646-652 https://doi.org/10.1136/gut.47.5.646
  54. Lilly DM, Tillwell RH. 1965. Probiotics: Growth promoting factors produced by microoraganisms. Science 147:747-748 https://doi.org/10.1126/science.147.3659.747
  55. Marteau P, Cuillerier E. Meance S, Gerhardt MF, Myara A, Bouvier M, Bouley C, Tondu F, Bommelaer G, Grimaud JC. 2002. Bifidobacterium animalis strain DN-173010 shortens the colonic transit time in healthy women: A double-blind, randomized, controlled study. Aliment Pharmacol Ther 16: 587-593 https://doi.org/10.1046/j.1365-2036.2002.01188.x
  56. Mashayckh M, Brown RJ. 1992. Stability of Lactobacillus bulgaricus, Streptococcus ssp. thermophilus and $\beta$-galactosidase activity in frozen cultures ice cream. Cult Dairy Prod J 27:4-8
  57. Meance SC, Raimondi C, Turchet A, Lucas P, Antoine C, Jean- Michel. 2003. Recent advances in the use of functional foods: Effects of the commercial fermented milk with Bifidobacterium animalis strain DN-173010 and yoghurt strains on gut transit time in the elderly. Microbial Ecol Health Disease 15:15-22 https://doi.org/10.1080/08910600310015565
  58. Metchnikoff E. 1908. The Prolongation of Life. G. P. Putnam and Sons, New York
  59. Morata A, Gonzalez VS, Perdigon G, Holgado AP, Oliver G. 1998. Immunostimulating activity of cell walls from lactic acid bacteria and related species. Food Agric Immunol 10:183-191 https://doi.org/10.1080/09540109809354981
  60. Munoz P, Bouza E, Cuenca-Estrella M, Eiros JM, Pelaez MJ. 2005. Saccharomyces cerevisiae fungemia: An emerging infectious disease. Clin Infect Dis 40:1625-1634 https://doi.org/10.1086/429916
  61. Nielen JW, Gilliland SE. 1992. The lactose hydrolyzing enzyme from Lactobacillus acidophilus. Cult Dairy Prod 27:20-28
  62. Nielsn JW, Dickson JS, Crouse JD. 1990. Use of a bacteriocin produced by Pediococcus acidilactici to inhibit Listeria monocytogenes associated with fresh mear. Appl Env Microbiol 56:2142-2145
  63. Nomoto K, Nagaoka M, Yokakura T, Muta M. 1989. Augmentation of resistance of mice to bacterial infection by a polysaccharide - peptidoglycan complex (PSPG) extracted from Lactobacillus casei. Biotherapy 1:169-177 https://doi.org/10.1007/BF02170886
  64. O`Sullivan MG, Thornton G, O`Sullivan GC, Collins JK. 1992. Probiotic bacteria: Myth of reality. Trends Food Sci Technol 3:309-314 https://doi.org/10.1016/S0924-2244(10)80018-4
  65. Pariza MW, Park Y, Cook ME. 2000. Mechanisms of action conjugated linoleic acid: Evidence and speculation. Proc Soc Exp Bilo Med 223:8-13 https://doi.org/10.1046/j.1525-1373.2000.22302.x
  66. Perdigon G, Alvarez S, Macia MEN, Roux ME, Ruiz Holgado AP. 1990. The oral adminstration of lactic acid bacteria increase the mucosal intestinal imunity in response to enteropathogen. J Food Protec 53:404-410 https://doi.org/10.4315/0362-028X-53.5.404
  67. Perdigon G, Alvarez S. 1992. Probiotics and the Immune State. pp. 145-180. Fuller
  68. Pongpech P, Hentges DJ. 1989. Inhibitory effects of volatile fatty and low pH on the multiplication of enteric pathogens in vitro in caecal contents of mice. Microb Ecol Health Dis 2:247-253 https://doi.org/10.3109/08910608909140227
  69. Price RJ, Lee JS. 1970. Inhibition of Pseudomonas species by hydrogen peroxide producing lactobacilli. J Milk Food Technol 33:13-20 https://doi.org/10.4315/0022-2747-33.1.13
  70. Raccach M, McGrath R, Daftarian H. 1989 Antibiosis of some lactic acid bacteria including Lactobacillus acidophilus toward Listeria monocytogenges. Int J Microbiol 9:25-35 https://doi.org/10.1016/0168-1605(89)90034-2
  71. Rautio M, Jousimies-Somer H, Kauma H, Pietarinen I, Saxelin M, Tynkkynen S, Koskela M. 1999. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 28:1159-1160 https://doi.org/10.1086/514766
  72. Reddy GV, Friend BA, Shahani KM, Farmer RE. 1983. Antitumor activity of yogurt components. J Food Prot 46:8-11 https://doi.org/10.4315/0362-028X-46.1.8
  73. Reddy GV, Shanhani KM, Friend MA, Chandan RC. 1984. Natuaral antibiotic activity of Lactobacillus acidophilus and bulgaricus. Cult Dairy Prod J 19:7-11
  74. Rhowmik T, Jhonson MC, Ray B. 1987. Factors influencing synthesis and activity of $\beta$-galactosidase in Lactobacillus acidophilus. J Indust Microbil 2:1-7 https://doi.org/10.1007/BF01569399
  75. Saavedra J, Abi-Hanna MA, Moore N, Yolken RH. 2004. Longterm consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr 79:261-267 https://doi.org/10.1093/ajcn/79.2.261
  76. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet- Hughes A. 1995. Immunomodulation of human blood cell following the ingestion of lactic acid bacteria. J Dairy Sci 78:491-497 https://doi.org/10.3168/jds.S0022-0302(95)76659-0
  77. Shahani KM, Friend BA, Bailey PJ. 1983. Antitumor activity of fermented colostrum and milk. J Food Protect 46:385-386 https://doi.org/10.4315/0362-028X-46.5.385
  78. Takano T, Arai K, Murota L, Hayakawa K, Mizutani T, Mtuoka T. 1985. Effects of feeding sour milk on longevity and tumorigenesis in mice and rats. Bifidobacteria Microflora 4:31-37 https://doi.org/10.12938/bifidus1982.4.1_31
  79. Thibault H, Jacquin A, Goulet O. 2004. Effects of long-term consumption of a fermented infant formula (with Bifidobacterium brevis c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. J Pediatr Gastroenterol Nutr 39:147-152 https://doi.org/10.1097/00005176-200408000-00004
  80. Tsuzuki S, Yamazaki S, Akashiba H, Kanimura H, Sekine K, Toida T, Saito M, Kawashima T, Ueda K. 1991. Tumorsuppresive effect of a cell wall preparation. WPG from Bifidobacterium infantis in germfree and flora-bearing mice. Bifidobact Microflora 10:43-52. https://doi.org/10.12938/bifidus1982.10.1_43
  81. Watanabe S, Narisawa Y, Arase S, Okamatsu H, lkenaga T, Tagira Y. 2003. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 111:587-591. https://doi.org/10.1067/mai.2003.105
  82. Whigham LD, Cook ME, Atkinson RL. 2000. Conjugated linoleic acid implications for human health. Pharmacol 42:503-510
  83. Yamazaki K, Hosono A, Hashimoto H, He F, Hosoda M, Kawase M. 1999. Hypochole-sterolemic effects of Lactobacillus casei subsp. casei TMC 0409 strain observed in rats fed cholesterol contained diets. Animal Sci J 70:90-97.
  84. Yasui H, Ohwaki M. 1991. Enhancement of immune response in Deyer patch cells cultured with Bifidobacterium breve. J Dairy Sci 74:133-140.
  85. Zhang EB, Ohta Y. 1991. Binding of mutagens by fractions of the cell wall keleton of lactic acid bacteria on mutagen. J Dairy Sci 74:1477-1481 https://doi.org/10.3168/jds.S0022-0302(91)78306-9
  86. 식품의약품안전청. 2008. 2.4.8 프락토올리고당, 2.5.1 프로바이오틱스. 건강기능식품공전
  87. 新家龍, 南浦能至, 北畑壽美雄, 大西正健. 1996. 糖質の科學, ビピフィズス因子活性, pp. 95-104 朝倉書店
  88. 田中隆一郞. 1990. 腸內細菌の利用, 腸內細菌學. pp. 426-439 朝倉書店

Cited by

  1. Physicochemical Properties and Antioxidant Activities of Black Raspberry, Black Chokeberry, Mulberry, and Blueberry during Lactic Acid Fermentation vol.33, pp.5, 2017, https://doi.org/10.9724/kfcs.2017.33.5.479
  2. Effect of Herbal Probiotic Supplementation on Weight, Blood Composition, Meat Quality and Immunity in Beef vol.29, pp.6, 2016, https://doi.org/10.9799/ksfan.2016.29.6.860
  3. Quality Characteristics and Antioxidant Activity of Espresso Coffee Prepared with Green Bean Fermented by Lactic Acid Bacteria vol.45, pp.12, 2016, https://doi.org/10.3746/jkfn.2016.45.12.1799
  4. Quality Properties of Yogurt Added with Hot Water Concentrates from Allium hookeri Root vol.43, pp.9, 2014, https://doi.org/10.3746/jkfn.2014.43.9.1415
  5. Quality properties of fermented mugworts and the rapid pattern analysis of their volatile flavor components via surface acoustic wave (SAW) based electronic nose sensor in the GC system vol.20, pp.4, 2013, https://doi.org/10.11002/kjfp.2013.20.4.554
  6. Characterization of Probiotic and Functional Properties of Lactobacillus curvatus ML17, a Mukeunji Starter vol.43, pp.7, 2014, https://doi.org/10.3746/jkfn.2014.43.7.1009
  7. Survey of Taking Dietary Supplements in Children Aged 1~8 Years vol.18, pp.2, 2014, https://doi.org/10.21896/jksmch.2014.18.2.196
  8. Biological Activity and Improvement Effect on Irritable Bowel Syndrome of Wax Gourd Extract and Probiotic Lactic Acid Bacteria vol.26, pp.1, 2013, https://doi.org/10.9799/ksfan.2013.26.1.137
  9. Lactobacillus plantarumLG42 Isolated from Gajami Sik-Hae Inhibits Adipogenesis in 3T3-L1 Adipocyte vol.2013, 2013, https://doi.org/10.1155/2013/460927
  10. Antioxidative Activity of Mushroom Water Extracts Fermented by Lactic Acid Bacteria vol.43, pp.1, 2014, https://doi.org/10.3746/jkfn.2014.43.1.080
  11. 전통 장류 유래 유산균을 이용한 콩 발효물의 품질특성 vol.24, pp.2, 2011, https://doi.org/10.11002/kjfp.2017.24.2.187
  12. 장내 세균 개선을 병행한 결절성 양진 치험 1례 vol.30, pp.3, 2017, https://doi.org/10.6114/jkood.2017.30.3.250
  13. 고초균 발효누에 추출물이 알코올성 지방간 유발 흰쥐에 미치는 간 기능 개선 효과 vol.28, pp.6, 2011, https://doi.org/10.5352/jls.2018.28.6.697
  14. 유아 분변에서 분리한 비피도박테리아의 프로바이오틱스 기능성 연구 vol.37, pp.1, 2019, https://doi.org/10.22424/jmsb.2019.37.1.40
  15. Lactobacillus rhamnosus BHN-LAB 76에 의한 Pueraria 발효 추출물의 항산화 활성 평가 vol.29, pp.5, 2011, https://doi.org/10.5352/jls.2019.29.5.545
  16. Lactobacillus plantarum BHN-LAB 33의 생물전환공정을 통한 방풍 발효 추출물의 항산화 활성 및 미백 활성 증대 효과 vol.29, pp.11, 2019, https://doi.org/10.5352/jls.2019.29.11.1208
  17. Inhibitory Effects of Lactobacillus plantarum Q180 on Lipid Accumulation in HepG2 Cells vol.32, pp.6, 2011, https://doi.org/10.9799/ksfan.2019.32.6.738
  18. 프로바이오틱스 Enterococcus faecium CKDB003의 항생제 내성 및 안전성 평가 vol.33, pp.3, 2020, https://doi.org/10.9799/ksfan.2020.33.3.223
  19. Change of Intestinal Microbial in Prototype Including Lactobacillus plantarum GBL16 and 17 Strains Isolated from Black Raspberry vol.54, pp.4, 2020, https://doi.org/10.14397/jals.2020.54.4.93
  20. Characterization of Lactobacillus paracasei JSRL18-60 with probiotic properties as a starter in manufacturing fermented milk vol.28, pp.1, 2011, https://doi.org/10.11002/kjfp.2021.28.1.147